dalbavancin hydrochloride
- RxCUI
- 1541465
- RxNorm name
- dalbavancin hydrochloride
- Term type
- PIN
- Status
- Active
- Updated
- 2026-09-29 04:12:27
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 082014
- Active start
- 082014
- Multiple ingredient
- NO
- Branded
- NO
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| dalbavancin | 1539239 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | dalbavancin hydrochloride | 1 | NAMES |
| RxNorm Name | dalbavancin hydrochloride | 1 | NAMES |
| TTY | PIN | 1 | ATTRIBUTES |
| SPL_SET_ID | 7 | CODES | |
| UNII_CODE | 33WDQ7T81E | 1 | CODES |
| RxCUI | 1541465 | 1 | CODES |
| MMSL_CODE | IN30328 | 1 | CODES |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| DALBAVANCIN HYDROCHLORIDE | DALBAVANCIN HYDROCHLORIDE | Fresenius Kabi USA, LLC | 2c2ec45e-48a2-4887-8ab0-9244eb39a394 | 2026-04-02 | Warnings, Adverse reactions | DALBAVANCIN HYDROCHLORIDE |
| Dalbavancin | DALBAVANCIN HYDROCHLORIDE | Long Grove Pharmaceuticals, LLC | 2a20d077-a5ba-4af3-a2d6-499c25b816d8 | 2026-02-17 | Warnings, Adverse reactions | DALBAVANCIN HYDROCHLORIDE |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
No records found.
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | J01XA | Glycopeptide antibacterials | ATC1-4 | dalbavancin | |
| FDASPL | D000077427 | Lipoglycopeptides | CHEM | has_chemical_structure | dalbavancin |
| FDASPL | N0000191281 | Lipoglycopeptide Antibacterial | EPC | has_epc | dalbavancin |
| MEDRT | D017334 | Teicoplanin | CHEM | has_ingredient | dalbavancin |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | dalbavancin |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | dalbavancin hydrochloride |
| MEDRT | D012874 | Skin Diseases, Infectious | DISEASE | may_treat | dalbavancin |
| MEDRT | D012874 | Skin Diseases, Infectious | DISEASE | may_treat | dalbavancin hydrochloride |
| MEDRT | D013203 | Staphylococcal Infections | DISEASE | may_treat | dalbavancin |
| MEDRT | D013203 | Staphylococcal Infections | DISEASE | may_treat | dalbavancin hydrochloride |
| MEDRT | D013290 | Streptococcal Infections | DISEASE | may_treat | dalbavancin |
| MEDRT | D013290 | Streptococcal Infections | DISEASE | may_treat | dalbavancin hydrochloride |
| MEDRT | N0000000150 | Protein Synthesis Inhibitors | MOA | has_moa | dalbavancin |
| MEDRT | N0000000150 | Protein Synthesis Inhibitors | MOA | has_moa | dalbavancin hydrochloride |
| MEDRT | N0000008479 | Decreased Cell Wall Synthesis & Repair | PE | has_pe | dalbavancin |
| MEDRT | N0000008479 | Decreased Cell Wall Synthesis & Repair | PE | has_pe | dalbavancin hydrochloride |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| CODES | SNOMEDCT | 703918006 |
| CODES | USP | m9504 |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | United States Pharmacopeia |
| SOURCES | Source | US Edition of SNOMED_CT |